Adjunctive 5% Lidocaine Patches for Acute Non-radicular Low Back Pain in Emergency Department Patients

• Status: Unknown status
• Trial end date: 2020-07-01
• Target enrollment: 0
• Participant gender: All

Summary

This study will evaluate the addition of lidocaine % transdermal patches to standard therapy in the treatment of acute non-radicular low back pain in patients discharged from the Emergency Department. In addition to standard therapy, half of the participants will receive medicated patches while the other half will receive non-medicated patches.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: John H. Stroger Hospital
• Treatments: Lidocaine

Criteria

Inclusion Criteria:

• pain originating between the lower border of the scapulae and the upper gluteal folds

• treating ED physician plan for discharge of the patient

Exclusion Criteria:

• radicular pain defined as pain radiating below the gluteal folds

• direct trauma to the back within previous month

• pain of greater than 2 weeks duration or greater than 1 LBP episode per month in the past 3 months

• patient being pregnant or lactating; no access to phone or ability to participate in follow-up phone calls

• known allergy to lidocaine or skin breakdown over site of pain

• treating physician plan for opioid prescription (tramadol, codeine, hydrocodone)

• personal history of malignancy, fever (temperature greater than 37.9ºC), or previous spinal surgery

• patients who are detainees

• previous enrollment in the study